載入...
695. Activity of Imipenem–Relebactam and Ceftolozane–Tazobactam Against a Contemporary Collection of Gram-Negative Bacteria from New York City
BACKGROUND: Carbapenem-resistant Gram-negative bacteria are important nosocomial pathogens, and therapeutic options are often limited. METHODS: Clinical isolates were gathered during a surveillance study in 2017 involving 7 hospitals in Brooklyn, NY. Isolates underwent susceptibility testing using t...
Na minha lista:
| 發表在: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811245/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.763 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|